trending Market Intelligence /marketintelligence/en/news-insights/trending/huyy1bvy13jidb7ginu9ha2 content esgSubNav
In This List

Danaher to acquire privately held DNA technology company

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Danaher to acquire privately held DNA technology company

Washington, D.C.-based business conglomerate Danaher Corp. is set to acquire privately held Integrated DNA Technologies Inc. for undisclosed terms.

Coralville, Iowa-based IDT manufactures custom DNA and RNA for use in academic and biopharmaceutical research. "IDT expands our presence into the highly attractive genomics market and will help play a central role in accelerating our customers' research and time to market as they develop critical diagnostic tests and potential life-saving therapies," Rainer Blair, executive vice president of Danaher's life sciences platform, said in a statement.

IDT has 1,200 employees and will operate as a stand-alone entity within Danaher's life sciences platform.

The deal, expected to close mid-year 2018, is subject to customary closing conditions and regulatory approvals.